9 articles
ACS Committee Chair Christine E. McCain comments on intellectual property challenges in AI-driven drug discovery, asserting that human inventors remain essential for patent applications despite AI gen
Nobel laureates and Priestley Medalists discussed the future of chemical sciences at the ACS Fall 2026 meeting. The panel offered insights from top scientists on the evolving role of the discipline.
University of Chicago researchers developed a novel skeletal editing technique to synthesize pyrrole compounds from isoxazoles, with findings published in Nature and presented at the ACS Fall 2026 mee
Thirty-one PhD students and postdocs selected for the 2026 CAS Future Leaders program will attend leadership training at CAS headquarters before participating in ACS Fall 2026.
An ACS member writes to C&EN praising chemistry's contributions while warning of challenges threatening US scientific leadership highlighted in the June issue.
Registration is now open for the ACS150 JACS Symposium Series, featuring global events including stops in Chicago and Cape Town throughout 2026.
Representatives from ACS and MilliporeSigma dedicated a Historic Chemical Landmark to Alfred Bader in Kingston, Ontario, honoring his contributions to chemistry. The event included Nobel laureate Barr
ACS President-Elect Christina Bodurow discussed her 40-year career in chemistry R&D and drug development during a recent podcast interview. She highlighted her transition from organometallic research
Jennifer Doudna, the 2026 Priestley Medalist, will present an address on CRISPR chemistry at the ACS Spring 2026 meeting, discussing the technology's impact on health and her scientific origins.
ChemBrief